This study compares drug-loaded oral films made with 3D printing and solvent casting, showing improved properties in 3D printed formulations.
From the perspective of DDSs, OFs have received increased attention, mainly for pediatric and geriatric applications. Beeswax, a naturally derived and FDA-approved material, is often mixed with other polymers to enhance its mechanical properties. This study presented the first use of precisely controlled, solvent-free pressure-assisted micro-syringe printing to produce OFs. Solvent casting and pressure-assisted micro-syringe printing were employed to produce hybrid film structures composed of beeswax, PVA, borax, and HPMC, loaded with betamethasone as a model drug. The films were characterized based on their physical appearance, mechanical attributes, surface structure, and ultrastructure morphology via SEM, drug content, and in vitro drug release. Films without the drug showed greater irregularities and roughness compared to the drug-loaded films. The physical properties of the formulations improved through 3D printing. By using 3D printing methods in pharmaceuticals, the treatment procedurewould be very acceptable to the patient and increases the patient's adherence to treatmentand is useful for personal drug delivery.
No takes yet. Share an insight, caveat, or question.
Torabi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: